Can You Lower A1C Without Medication? — Metabolic Clarity Labs

Can You Lower A1C Without Medication? What the Evidence Shows

One of the largest diabetes prevention trials ever run found something genuinely surprising: structured lifestyle change outperformed a proven medication. Here's what it actually found, and what it didn't.

By Charles Kirkland, Founder, Metabolic Clarity Labs
Updated August 2026

Quick answer: The landmark Diabetes Prevention Program, a large NIH-funded randomized trial, found that a structured lifestyle intervention aiming for 7% weight loss and 150 minutes of weekly activity reduced diabetes incidence by 58% compared with placebo, versus 31% for metformin, over an average of 2.8 years. When outcomes were later analyzed by A1C-based criteria specifically, lifestyle and metformin performed similarly, at 49% and 44% reduction respectively. This is strong evidence that structured lifestyle change can meaningfully affect diabetes risk and glucose markers, though individual results vary and lifestyle change doesn't work identically for everyone.

The trial that changed how this question gets answered

The Diabetes Prevention Program, or DPP, enrolled 3,234 adults with elevated glucose who were at high risk for developing type 2 diabetes. Participants were randomly assigned to one of three groups: placebo, metformin, or an intensive lifestyle intervention with a goal of 7% body weight loss and at least 150 minutes of physical activity per week, delivered through a structured program with individual counseling.

After an average follow-up of 2.8 years, the results were clear enough that the trial's independent monitoring board stopped it early: the lifestyle intervention reduced the development of diabetes by 58% compared with placebo. Metformin reduced it by 31% compared with placebo. Lifestyle intervention was significantly more effective than the medication, not just similarly effective.

What actually happened to the numbers

In the lifestyle group, fasting glucose declined from a mean of 107 to 101 mg/dL, while the placebo group showed no meaningful change. Half of the lifestyle group achieved the 7% weight-loss goal within 24 weeks, and 74% achieved the physical activity goal.

When researchers later reanalyzed the trial's outcomes using currently accepted A1C-based diagnostic criteria specifically, lifestyle intervention and metformin performed comparably: a 49% reduction in diabetes incidence for lifestyle versus 44% for metformin. This is a meaningfully different picture from the original headline numbers, and it's worth understanding why: the original 58% versus 31% comparison used a broader diagnostic definition, while the A1C-specific reanalysis narrowed the comparison to the exact metric most people care about when they ask this question.

What happened over the following decades

Long-term follow-up through the Diabetes Prevention Program Outcomes Study tracked participants for up to 21 years. The advantage of both interventions diminished over time compared with the original 3-year results, but remained real: over the full follow-up period, lifestyle intervention reduced diabetes development by 24% and metformin by 17%, both still compared with the original placebo group. The median time before a diabetes diagnosis was extended by 3.5 years in the lifestyle group and 2.5 years in the metformin group.

This matters because it answers a fair question: does an early lifestyle change actually hold up, or does the benefit fade completely? The data says the benefit fades somewhat but doesn't disappear, even decades later.

Does adding metformin to lifestyle change help more?

A 2024 meta-analysis of 12 randomized trials found that adding metformin to lifestyle interventions did produce a significantly greater reduction in A1C at 3 and 6 months compared with lifestyle interventions alone. However, by 12 months, the pooled studies found no significant difference between the combined approach and lifestyle alone. This suggests metformin may accelerate early improvement without necessarily producing a larger improvement over the longer term, at least in this specific comparison.

Whether adding metformin makes sense for any individual person is a decision that depends on personal risk factors, and research has found metformin's benefit varies notably by subgroup: it was less effective in people with a BMI between 22 and 30 and in adults 60 and older, compared with its effect in higher-BMI, younger participants.

What the DPP protocol actually involved

It's worth being precise about what was studied, since "lifestyle change" gets used loosely elsewhere. The DPP's intensive lifestyle intervention specifically targeted 7% weight loss through a structured dietary program, combined with at least 150 minutes per week of moderate physical activity, delivered through individual counseling sessions rather than a generic pamphlet or app. This was a resourced, structured, professionally supported program, not simply "eat better and move more" advice given once.

This distinction matters because results from unstructured, unsupported attempts at the same general goals may not match what a structured, supported program can achieve.

What this evidence doesn't tell you

It doesn't tell you your personal expected result, since the DPP reports population-level averages across a large, specific study group with elevated glucose and high diabetes risk at enrollment.

It doesn't mean lifestyle change works identically for everyone; even within the trial, individual responses varied substantially.

It doesn't mean medication is unnecessary for people who are already diagnosed with diabetes rather than at risk for it; the DPP studied prevention in a high-risk but not-yet-diabetic population.

It doesn't replace an individualized conversation with your clinician about which approach, or combination, fits your specific situation, medications, and health history.

What this means practically

If you're in the prediabetes range, this evidence supports discussing a structured lifestyle program with your clinician as a genuinely evidence-backed option, not a consolation prize compared with medication.

If you're already taking metformin or another glucose-lowering medication, this evidence doesn't mean you should stop it; the DPP doesn't answer that question, since it was a prevention trial rather than a study of stopping established treatment.

The CDC's National Diabetes Prevention Program is a structured, evidence-based option modeled directly on the DPP trial and may be worth asking your clinician about by name.

Frequently asked questions

Can lifestyle changes really work as well as medication for A1C?

In the DPP's A1C-specific reanalysis, lifestyle intervention and metformin performed comparably, at 49% versus 44% diabetes-incidence reduction. The original broader analysis actually favored lifestyle intervention.

How much weight loss did the study use as its target?

The DPP's lifestyle intervention targeted 7% body weight loss combined with at least 150 minutes of weekly physical activity, delivered through a structured, professionally supported program.

Does the benefit of lifestyle change last long-term?

Yes, though it diminishes over time. Twenty-one-year follow-up still showed a 24% reduction in diabetes development for the lifestyle group compared with the original placebo group.

Should I add metformin to my lifestyle changes?

This is an individual decision for you and your clinician. Evidence suggests metformin may speed up early A1C improvement without necessarily improving 12-month outcomes beyond lifestyle change alone, and its effectiveness appears to vary by age and BMI.

Can I get the same results without a structured program?

This isn't something the DPP evidence directly answers, since the trial used a structured, professionally supported intervention. A structured program, including options like the CDC's National Diabetes Prevention Program, may offer advantages over an unsupported, self-directed attempt at similar goals.

The Metabolic Clarity takeaway

The Diabetes Prevention Program is one of the most rigorously studied answers to this question that exists, and it says structured lifestyle change can be a genuinely powerful, evidence-backed approach, not just a softer alternative to medication. What it can't do is promise an identical result to any individual reading this article.

Next step: Read the complete guide to A1C to understand your current category, then ask your clinician whether a structured program modeled on the DPP, such as the CDC's National Diabetes Prevention Program, is appropriate for your situation.

Sources

Charles Kirkland is the founder of Metabolic Clarity Labs. He is not a physician. His writing is based on his own documented health experience, alongside cited research sources.

Medical and regulatory disclaimer: This article is for general education only. It does not diagnose, treat, or prevent disease and does not replace advice from a physician or other qualified health professional. Do not start, stop, or change a diabetes medication based on this article. Seek prompt medical care for symptoms of very high or very low blood glucose, including confusion, severe weakness, fainting, or difficulty breathing.

Back to blog